| 0 (0%) | 09-27 09:34 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 7.48 | 1-year : | 9.34 |
| Resists | First : | 6.4 | Second : | 8 |
| Pivot price | 6.06 |
|||
| Supports | First : | 3.82 | Second : | 3.18 |
| MAs | MA(5) : | 4.19 |
MA(20) : | 6.22 |
| MA(100) : | 4.44  |
MA(250) : | 3.96 |
|
| MACD | MACD : | -0.4 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 8.6 | D(3) : | 8.6 |
| RSI | RSI(14): 34.6 | |||
| 52-week | High : | 11.46 | Low : | 2.08 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ SINO ] has closed above bottom band by 16.8%. Bollinger Bands are 222.7% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Fri, 26 Sep 2025
Sino-Bangladeshi friendship hailed - China Daily
Fri, 26 Sep 2025
Sino Land (OTCMKTS:SNLAY) Trading Down 5.2% - Here's Why - MarketBeat
Thu, 25 Sep 2025
Sino Biopharmaceutical Advances LM-350 Clinical Trials in Australia - TipRanks
Tue, 23 Sep 2025
Zambia Still Grappling With Impact of Chinese Mining Disaster - Africa Defense Forum
Thu, 11 Sep 2025
Trump withdraws nomination of China hawk for key post in US-Sino tech battle - Reuters
Sat, 06 Sep 2025
Second Sino-Japanese War - Stalemate, Invasion, Conflict - Britannica
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 16 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 17.8 (%) |
| Held by Institutions | 4.1 (%) |
| Shares Short | 1,140 (K) |
| Shares Short P.Month | 841 (K) |
| EPS | -0.78 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 3.34 |
| Profit Margin | -154 % |
| Operating Margin | -129.6 % |
| Return on Assets (ttm) | -15.7 % |
| Return on Equity (ttm) | -38 % |
| Qtrly Rev. Growth | 58 % |
| Gross Profit (p.s.) | 0.01 |
| Sales Per Share | 0.35 |
| EBITDA (p.s.) | -0.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -3 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -5.44 |
| PEG Ratio | 0 |
| Price to Book value | 1.25 |
| Price to Sales | 11.64 |
| Price to Cash Flow | -19.45 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | 2020-07-06 |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|